# US 2012/0258879 A1 · Polymorphism Detection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0258879 A1
- Document ID: US20120258879A1
- Status: Published application
- Kind: A1
- Application number: 13/297,072
- Filed: 2011-11-15
- Published: 2012-10-11
- Earliest claimed: 1995-11-29
- Assignees: Affymetrix, Inc.
- Inventors: Robert J. Lipshutz; Ronald Sapolsky; Ghassan Ghandour
- Web page: https://patentgrep.com/patent/US20120258879A1

## CPC

- C07H 21/04: with deoxyribosyl as saccharide radical
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- G16B 25/00: ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- B01J 2219/00432: Photolithographic masks
- B01J 2219/00608: DNA chips
- B01J 2219/00626: Covalent
- B01J 2219/00659: Two-dimensional arrays
- B01J 2219/00711: Light-directed synthesis
- B01J 2219/00722: Nucleotides
- C40B 40/06: Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B 60/14: for creating libraries
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- Y10T 436/143333: Saccharide [e.g., DNA, etc.]
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention generally provides a rapid efficient method for analyzing polymorphic or biallelic markers, and arrays for carrying out these analyses. In general, the methods of the present invention employ arrays of oligonucleotide probes that are complementary to target nucleic acids which correspond to the marker sequences of an individual. The probes are typically arranged in detection blocks, each block being capable of discriminating the three genotypes for a given marker, i.e., the heterozygote or either of the two homozygotes. The method allows for rapid, automatable analysis of genetic linkage to even complex polygenic traits

## Claims

### Claim 1

An array of oligonucleotide probes for detecting a polymorphism in a target nucleic acid sequence using principal component analysis, said array comprising at least one detection block of probes, said detection block including a first group of probes that are complementary to said target nucleic acid sequence except that the group of probes includes all possible monosubstitutions of positions in said sequence that are within n bases of a base in said sequence that is complementary to said polymorphism, wherein n is from 0 to 5, and a second and third group of probes complementary to marker-specific regions upstream and downstream of the target nucleic acid sequence, wherein the third group of probes differs from the second set of probes at single bases corresponding to known mismatch positions:

### Claim 2 (depends on 1)

The array of claim 1, wherein the polymorphism is identified as a result of Principal Component Analysis of hybridization intensities of the array of probes.

### Claim 3 (depends on 1)

The array of claim 1, wherein at least two alleles of the polymorphism are known.

### Claim 4 (depends on 1)

The array of claim 1, wherein said first group of probes comprises a plurality of different probes that are complementary to overlapping portions of said target nucleic acid sequence.

### Claim 5 (depends on 1)

The array of claim 1, wherein the monosubstitutions occur at a plurality of distances from a 3′ end of said probes.

### Claim 6 (depends on 1)

The array of claim 1, wherein said detection block includes between about 8 and 88 different probes.

### Claim 7 (depends on 1)

The array of claim 1, comprising between 1 and 1,000 different detection blocks, each of said detection blocks including probes complementary to different polymorphisms in said target nucleic acid sequence.

### Claim 8

A method of identifying whether a target nucleic acid sequence includes a polymorphic variant using principal component analysis, comprising:
hybridizing said target nucleic acid sequence to said array comprising at least one detection block of probes, said detection block including a first group of probes that are complementary to said target nucleic acid sequence except that the group of probes includes all possible monosubstitutions of positions in said sequence that are within n bases of a base in said sequence that is complementary to said polymorphism, wherein n is from 0 to 5, and a second and third group of probes complementary to marker-specific regions upstream and downstream of the target nucleic acid sequence, wherein the third group of probes differs from the second set of probes at single bases corresponding to known mismatch positions, and
determining hybridization intensities of the target nucleic acid and the marker-specific regions to identify said polymorphic variant.

### Claim 9 (depends on 8)

The method of claim 8, wherein said target nucleic acid comprises a detectable label.

### Claim 10 (depends on 9)

The method of claim 9, wherein said detectable label is a fluorescent group.

### Claim 11 (depends on 9)

The method of claim 9, wherein said label is a binding group.

### Claim 12 (depends on 11)

The method of claim 11, wherein said binding group is selected from biotin, avidin and streptavidin.

### Claim 13 (depends on 8)

The method of claim 8, wherein the polymorphism is identified as a result of Principal Component Analysis of hybridization intensities of the array of probes.

### Claim 14 (depends on 8)

The method of claim 8, wherein at least two alleles of the polymorphism are known.

### Claim 15 (depends on 8)

The method of claim 8, wherein said step of determining comprises
a) calculating the control difference between the average of the hybridization intensities of the second group of probes, the hybridization intensities comprising control perfect matches (PM), minus the average of the hybridization intensities, the hybridization intensities comprising control single-base mismatches (MM),
b) calculating the possible perfect match intensity and a heteromismatch intensity from the hybridization intensities for each position of monosubstitutions of the first group of probes;
c) calculating the difference between the possible perfect match intensity and the heteromismatch intensity for each position of monosubstitutions of the first group of probes;
d) calculating a normalized difference (ND) by dividing the difference of step (c) by the control difference;
(e) using principal component analysis, identifying a polymorphism by comparing normalized differences between individuals in a population.

### Claim 16 (depends on 15)

The method of claim 15, wherein an ND is calculated for at least two allele of a polymorphism.

### Claim 17 (depends on 16)

The method of claim 16, wherein homozygotes and heterozygotes are detected by combining principal component analysis for two alleles.
